Life Science Sales, Currency Effects Pull Bio-Rad's Q1 Revenue Down 5 Percent | GenomeWeb

NEW YORK (GenomeWeb News) – Bio-Rad Laboratories reported after the market close on Tuesday that its first-quarter revenues fell 5 percent on lower life science products sales and the negative effect of foreign currency translation.

The firm reported total revenues of $400.9 million for the three-month period ended March 31, compared to revenues of $422.2 million for the first quarter of 2008. The company said that excluding foreign currency effects, its revenues increased around 3 percent year over year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.